The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-amino-9-[2,3-dideoxy-3-(hydroxymethyl)-alpha-D-erythro-pentofuranosyl]-9H-purine-6(1H)-thione ID: ALA3230222
PubChem CID: 23568330
Max Phase: Preclinical
Molecular Formula: C11H15N5O3S
Molecular Weight: 297.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc2c(ncn2[C@@H]2C[C@H](CO)[C@@H](CO)O2)c(=S)[nH]1
Standard InChI: InChI=1S/C11H15N5O3S/c12-11-14-9-8(10(20)15-11)13-4-16(9)7-1-5(2-17)6(3-18)19-7/h4-7,17-18H,1-3H2,(H3,12,14,15,20)/t5-,6-,7+/m1/s1
Standard InChI Key: JFXDHZJSWZPYOX-QYNIQEEDSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
11.2384 -10.5616 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.2384 -11.3788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9437 -11.7832 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9437 -10.1489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6490 -10.5616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6490 -11.3798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4271 -11.6327 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9081 -10.9707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4272 -10.3088 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9437 -9.3317 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.5313 -11.7884 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.6796 -12.4099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1999 -13.0688 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6802 -13.7300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4574 -13.4775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4574 -12.6603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4276 -14.5071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1186 -13.9578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6282 -14.6770 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.8651 -13.6254 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 2 0
2 11 1 0
12 7 1 6
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
14 17 1 1
15 18 1 6
17 19 1 0
18 20 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 297.34Molecular Weight (Monoisotopic): 297.0896AlogP: -0.04#Rotatable Bonds: 3Polar Surface Area: 122.21Molecular Species: NEUTRALHBA: 8HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.99CX Basic pKa: 1.44CX LogP: -1.24CX LogD: -1.24Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.59Np Likeness Score: 0.68
References 1. Acton EM, Goerner RN, Uh HS, Ryan KJ, Henry DW, Cass CE, LePage GA.. (1979) Improved antitumor effects in 3'-branched homologues of 2'-deoxythioguanosine. Synthesis and evaluation of thioguanine nucleosides of 2,3-dideoxy-3-(hydroxymethyl)-D-erythro-pentofuranose., 22 (5): [PMID:582321 ] [10.1021/jm00191a012 ]